Pharmaseed offers a wide range of anti-cancer development models. These include the ability to examine the metastatic activity of cancer cells after they are administered into the host systematically. This enables Pharmaseed to fully evaluate the anti-metastatic potential of drug and treatment candidates.
Anti Metastatic Activity Model
Tumor cells (Lewis Lung Adenocarcinoma) were injected through tail vein, 21 days post inoculation mice were sacrificed and assessed for lungs metastases.